Omnicell Inc. Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2012; Provides Earnings Guidance for the First Quarter and Year 2013
January 01, 2013 at 02:42 am IST
Share
Omnicell Inc. announced unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2012. For the quarter, the company announced total revenue of $90,169,000 compared to $62,931,000 for the same period a year ago. Income from operations was $9,791,000 compared to $6,169,000 for the same period a year ago. Income before provision for income taxes was $9,683,000 compared to $6,102,000 for the same period a year ago. Net income was $5,515,000 compared to $4,138,000 for the same period a year ago. Net income per share, diluted was $0.16 compared to $0.12 for the same period a year ago. Non-GAAP net income was $8,582,000 or $0.25 per diluted share compared to $6,383,000 or $0.19 per diluted share for the same period a year ago. Non-GAAP adjusted EBITDA was $16,191,000 compared to $10,489,000 for the same period a year ago.
For the year, the company announced total revenue of $314,027,000 compared to $245,535,000 for the same period a year ago. Income from operations was $27,083,000 compared to $16,222,000 for the same period a year ago. Income before provision for income taxes was $27,032,000 compared to $16,089,000 for the same period a year ago. Net income was $16,161,000 compared to $10,389,000 for the same period a year ago. Net income per share, diluted was $0.47 compared to $0.30 for the same period a year ago. Non-GAAP net income was $29,816,000 or $0.87 per diluted share compared to $20,508,000 or $0.60 per diluted share for the same period a year ago. Non-GAAP adjusted EBITDA was $54,376,000 compared to $34,367,000 for the same period a year ago. Free cash flow was over $25 million.
In 2013, the company will have a full year of revenue from MTS Solutions sold to Non-Acute Care customers. The company expects revenue to be between $370 million and $380 million, an increase of 18% to 21%. The company expects non-GAAP earnings to be between $0.97 and $1.05 per share, up 11% to 20%.
The company expected steady revenue and earnings growth through the year, but the company expect first quarter of 2013 to be $86 million to $88 million of revenue and approximately $0.19 non-GAAP EPS.
Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Companyâs XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.
Omnicell Inc. Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2012; Provides Earnings Guidance for the First Quarter and Year 2013